Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search

Sign up for NAQC membership today!


Receive a monthly issue of Connections!
NAQC Newsroom: Research

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Find

Thursday, January 23, 2020  
Posted by: Natalia Gromov
Toumazis I, Tsai EB, Erdogan SA, Han SS, Wan W, Leung A, Plevritis SK.
Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings.
JNCI Cancer Spectr. 2019 May 23;3(3):pkz035. doi: 10.1093/jncics/pkz035. eCollection 2019 Sep.
 
Numerous health policy organizations recommend lung cancer screening, but no consensus exists on the optimal policy. Moreover, the impact of the Lung CT screening reporting and data system guidelines to manage small pulmonary nodules of unknown significance (a.k.a. indeterminate nodules) on the cost-effectiveness of lung cancer screening is not well established.

The disutility associated with indeterminate findings impacts the cost-effectiveness of lung cancer screening. Efforts to quantify and better understand the impact of indeterminate findings on the effectiveness and cost-effectiveness of lung cancer screening are warranted.


Sign In


Latest News

 

       Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 | email:naqc@naquitline.org